249 related articles for article (PubMed ID: 34296293)
21. Everolimus prevents doxorubicin-induced apoptosis in H9c2 cardiomyocytes but not in MCF-7 cancer cells: Cardioprotective roles of autophagy, mitophagy, and AKT.
Kanno SI; Hara A
Toxicol In Vitro; 2023 Dec; 93():105698. PubMed ID: 37739323
[TBL] [Abstract][Full Text] [Related]
22. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
Lee KH; Cho H; Lee S; Woo JS; Cho BH; Kang JH; Jeong YM; Cheng XW; Kim W
Int J Cardiol; 2017 Apr; 232():40-47. PubMed ID: 28159361
[TBL] [Abstract][Full Text] [Related]
23. Paradoxically, iron overload does not potentiate doxorubicin-induced cardiotoxicity in vitro in cardiomyocytes and in vivo in mice.
Guenancia C; Li N; Hachet O; Rigal E; Cottin Y; Dutartre P; Rochette L; Vergely C
Toxicol Appl Pharmacol; 2015 Apr; 284(2):152-62. PubMed ID: 25711856
[TBL] [Abstract][Full Text] [Related]
24. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting the expression of peroxiredoxin III in H9c2 cells.
Liu MH; Lin XL; Yuan C; He J; Tan TP; Wu SJ; Yu S; Chen L; Liu J; Tian W; Chen YD; Fu HY; Li J; Zhang Y
Mol Med Rep; 2016 Jan; 13(1):367-72. PubMed ID: 26573464
[TBL] [Abstract][Full Text] [Related]
25. N-acetylcysteine amide decreases oxidative stress but not cell death induced by doxorubicin in H9c2 cardiomyocytes.
Shi R; Huang CC; Aronstam RS; Ercal N; Martin A; Huang YW
BMC Pharmacol; 2009 Apr; 9():7. PubMed ID: 19368719
[TBL] [Abstract][Full Text] [Related]
26. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
[TBL] [Abstract][Full Text] [Related]
27. HMOX1 silencing prevents doxorubicin-induced cardiomyocyte injury, mitochondrial dysfunction, and ferroptosis by downregulating CTGF.
Qian J; Wan W; Fan M
Gen Thorac Cardiovasc Surg; 2023 May; 71(5):280-290. PubMed ID: 36008747
[TBL] [Abstract][Full Text] [Related]
28. Punicalagin protects H9c2 cardiomyocytes from doxorubicin-induced toxicity through activation of Nrf2/HO-1 signaling.
Ye M; Zhang L; Yan Y; Lin H
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015369
[TBL] [Abstract][Full Text] [Related]
29. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells.
Dallons M; Alpan E; Schepkens C; Tagliatti V; Colet JM
Cells; 2020 Sep; 9(10):. PubMed ID: 32992522
[TBL] [Abstract][Full Text] [Related]
30. Naringin protects myocardial cells from doxorubicin‑induced apoptosis partially by inhibiting the p38MAPK pathway.
Jian CY; Ouyang HB; Xiang XH; Chen JL; Li YX; Zhou X; Wang JY; Yang Y; Zhong EY; Huang WH; Zhang HW
Mol Med Rep; 2017 Dec; 16(6):9457-9463. PubMed ID: 29152646
[TBL] [Abstract][Full Text] [Related]
31. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting reactive oxygen species-activated extracellular signal-regulated kinase 1/2 in H9c2 cardiac myocytes.
Liu MH; Lin XL; Zhang Y; He J; Tan TP; Wu SJ; Liu J; Tian W; Chen L; Yu S; Li J; Yuan C
Mol Med Rep; 2015 Nov; 12(5):6841-8. PubMed ID: 26299281
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of serum and glucocorticoid-regulated kinase 1 (SGK1) ameliorates doxorubicin-induced cardiotoxic injury, apoptosis, inflammation and oxidative stress by suppressing glucose regulated protein 78 (GRP78)-mediated endoplasmic reticulum stress.
Wang F; Han L
Bioengineered; 2022 Jan; 13(1):844-855. PubMed ID: 34898378
[TBL] [Abstract][Full Text] [Related]
33. Hydrogen sulfide protects H9c2 cells against doxorubicin-induced cardiotoxicity through inhibition of endoplasmic reticulum stress.
Wang XY; Yang CT; Zheng DD; Mo LQ; Lan AP; Yang ZL; Hu F; Chen PX; Liao XX; Feng JQ
Mol Cell Biochem; 2012 Apr; 363(1-2):419-26. PubMed ID: 22203419
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol protects against doxorubicin-induced cardiotoxicity by attenuating ferroptosis through modulating the MAPK signaling pathway.
Chen L; Sun X; Wang Z; Chen M; He Y; Zhang H; Han D; Zheng L
Toxicol Appl Pharmacol; 2024 Jan; 482():116794. PubMed ID: 38142782
[TBL] [Abstract][Full Text] [Related]
35. LCZ696 protects against doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via AKT/SIRT3/SOD2 signaling pathway activation.
Liu X; Li D; Pi W; Wang B; Xu S; Yu L; Yao L; Sun Z; Jiang J; Mi Y
Int Immunopharmacol; 2022 Dec; 113(Pt A):109379. PubMed ID: 36330913
[TBL] [Abstract][Full Text] [Related]
36. Aloe-emodin alleviates doxorubicin-induced cardiotoxicity via inhibition of ferroptosis.
He Y; Xi J; Fang J; Zhang B; Cai W
Free Radic Biol Med; 2023 Sep; 206():13-21. PubMed ID: 37364691
[TBL] [Abstract][Full Text] [Related]
37. Peptide Szeto‑Schiller 31 ameliorates doxorubicin‑induced cardiotoxicity by inhibiting the activation of the p38 MAPK signaling pathway.
Zhang L; Feng M; Wang X; Zhang H; Ding J; Cheng Z; Qian L
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33649779
[TBL] [Abstract][Full Text] [Related]
38. Hydrogen sulfide protects H9c2 cardiac cells against doxorubicin-induced cytotoxicity through the PI3K/Akt/FoxO3a pathway.
Liu MH; Zhang Y; He J; Tan TP; Wu SJ; Guo DM; He H; Peng J; Tang ZH; Jiang ZS
Int J Mol Med; 2016 Jun; 37(6):1661-8. PubMed ID: 27081862
[TBL] [Abstract][Full Text] [Related]
39. Mesenchymal stem cells attenuate doxorubicin‑induced cellular senescence through the VEGF/Notch/TGF‑β signaling pathway in H9c2 cardiomyocytes.
Chen L; Xia W; Hou M
Int J Mol Med; 2018 Jul; 42(1):674-684. PubMed ID: 29693137
[TBL] [Abstract][Full Text] [Related]
40. Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C.
Ludke A; Akolkar G; Ayyappan P; Sharma AK; Singal PK
PLoS One; 2017; 12(7):e0179452. PubMed ID: 28678856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
